slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 35,941-35,970
Pages 2,019
Rows per page 30
Component
35,941-35,970 of 60,557
16
The table highlights median lines of therapy and specific categories of prior treatment exposure.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
Clinical trial data presentation showing mPFS and Hazard Ratios.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
Includes hazard ratios, confidence intervals, p-values, and median overall survival (mOS) for each cohort.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
Includes detailed footnotes defining abbreviations and study parameters.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses a matrix-like layout to show standard of care vs. clinical trial intervention points.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide presents clinical trial data (Kaplan-Meier curve and summary table) and a trial design flowchart.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
Includes waterfall plot and spider plots for clinical trial data.AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
The slide presents clinical trial data comparing T-DXd against TPC in two patient cohorts (HR+ and HR-).AstraZeneca | Investor Day Presentation Deck | 43 slides · AstraZeneca
Conference presentation Investor relations 1 hit
04
Azek | Investor Day Presentation Deck | 166 slidesAzek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Attention1 hit
49
The slide uses a timeline-like structure to show product evolution.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
109
The slide highlights the growth in manufacturing and recycling capacity through acquisitions and expansions.Azek | Investor Day Presentation Deck | 166 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
18
Includes adjustments for exchange rates, divestitures, and discontinuations.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
19
Includes non-GAAP reconciliation disclosure.Bausch Health Companies | Shareholder Engagement Presentation Deck | 19 slides · Bausch Health
Shareholder letter Investor relations 1 hit
17
The slide uses a hub-and-spoke diagram to link the company to its five capital allocation priorities.BenevolentAI | Investor Presentation Deck | 19 slides · BenevolentAI
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style visualization to show clinical trial phases for drug candidates.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
13
The slide uses checkmarks for completed or ongoing items and stars for future milestones.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
04
The slide uses a standard pharmaceutical pipeline visualization format.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
07
The slide uses a checkmark/cross matrix to highlight the competitive advantage of BNC210.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
23
The slide highlights the transition from automated computational prediction to human expert verification.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
25
Source: Lang F, et al. Nature Rev Drug Discov 2022; 21:261-282.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
30
The slide uses a structured table format to map technical mRNA variations to clinical outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
33
The slide uses a matrix-like table to show the application of different mRNA technologies across a portfolio of infectious disease programs.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
34
Includes schematic of lipid bilayer structure, RNA-lipoplex screening process, and bioluminescence imaging data.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
41
The slide illustrates the methodology for ranking neoantigens, likely for personalized cancer vaccine development.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
69
The table highlights the seroresponse difference and non-inferiority status for participants without prior infection.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
74
The slide uses a circular phylogenetic tree to illustrate the dominance of the Omicron clade (GRA) in recent outbreak sequences.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit